FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns by Harri Weber from Gizmodo on 2024-08-10 19:34 (#6PWJF) Lykos, the developer of the MDMA-assisted therapy for PTSD, called the FDA's request for more phase 3 research "deeply disappointing."
